Dandekar Atul bought MAZE
December 29, 2025 · Form 4 insider transaction
Dandekar Atul bought 72,400 shares of Maze Therapeutics, Inc. at $10.42 per share, a transaction worth $754.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
72,400
Price
$10.42
Total value
$754.4K
InsiderDandekar Atul
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 29, 2025
Filing dateDecember 31, 2025
Shares owned after82,903
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.; The reported total includes 1,562 shares of the Issuer's Common Stock acquired by the reporting person in one or more transactions with the Issuer pursuant to its Employee Stock Purchase Plan, which transactions are exempt pursuant to Rules 16a3(f)(1)(i)(B) and 16b3(c).